Difficulty: Medium
Average Score: 89%
Practice
Diamond Blackfan anemia is different from Transient Erythroblastopenia of Childhood as the former has
Correct answer
A
Rationale
Diamond Blackfan anemia (DBA) and Transient Erythroblastopenia of Childhood (TEC) are two distinct pediatric hematologic disorders. The correct answer, A) Increased adenosine deaminase, is specific to DBA. Adenosine deaminase levels are elevated in DBA due to ribosomal protein gene mutations. This characteristic distinguishes DBA from TEC.
Option B) Mean corpuscular volume is decreased is incorrect for DBA. DBA typically presents with macrocytic anemia, leading to an increased mean corpuscular volume.
Option C) Female predominance is incorrect for DBA. DBA shows no gender predilection and affects males and females equally.
Option D) Antecedent history of viral illness is more commonly associated with TEC, not DBA. TEC often follows a viral infection, leading to transient erythroblastopenia.
In an educational context, understanding the unique features of different pediatric cardiovascular disorders is crucial for accurate diagnosis and management. By differentiating between DBA and TEC, healthcare providers can provide appropriate interventions and support for affected children. This question highlights the importance of recognizing key clinical characteristics to differentiate between similar conditions in pediatric pharmacology and nursing practice.
Option B) Mean corpuscular volume is decreased is incorrect for DBA. DBA typically presents with macrocytic anemia, leading to an increased mean corpuscular volume.
Option C) Female predominance is incorrect for DBA. DBA shows no gender predilection and affects males and females equally.
Option D) Antecedent history of viral illness is more commonly associated with TEC, not DBA. TEC often follows a viral infection, leading to transient erythroblastopenia.
In an educational context, understanding the unique features of different pediatric cardiovascular disorders is crucial for accurate diagnosis and management. By differentiating between DBA and TEC, healthcare providers can provide appropriate interventions and support for affected children. This question highlights the importance of recognizing key clinical characteristics to differentiate between similar conditions in pediatric pharmacology and nursing practice.